Salutensin
Salutensin Brand names, Salutensin Analogs
- Cam-Ap-Es
- Demi-Regroton
- Diupres-250
- Diupres-500
- Diutensen-R
- Dralserp
- Hiserpia
- Hydrap-ES
- Hydromox R
- Hydroserpine Plus (R-H-H)
- Metatensin #2
- Metatensin #4
- Naquival
- Novoreserpine
- Rau-Sed
- Regroton
- Renese-R
- Reserfia
- Salutensin
- Salutensin-Demi
- Sandril
- Ser-A-Gen
- Serpalan
- Serpalan (TN)
- Serpanray
- Serpasil
- Serpasil-Apresoline
- Serpasil-Esidrix #1
- Serpasil-Esidrix #2
- Serpate
- Serpivite
- Unipres
Salutensin Brand Names Mixture
- Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
- Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
- SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)
Salutensin Chemical_Formula
C33H40N2O9
Salutensin RX_link
No information avaliable
Salutensin fda sheet
Salutensin msds (material safety sheet)
Salutensin Synthesis Reference
No information avaliable
Salutensin Molecular Weight
608.679 g/mol
Salutensin Melting Point
264.5 oC
Salutensin H2O Solubility
73 mg/L
Salutensin State
Solid
Salutensin LogP
3.32
Salutensin Dosage Forms
Tablets
Salutensin Indication
Foe the treatment of hypertension
Salutensin Pharmacology
Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.
Salutensin Absorption
No information avaliable
Salutensin side effects and Toxicity
Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg
Salutensin Patient Information
No information avaliable
Salutensin Organisms Affected
Humans and other mammals
